drugset / Trial / NCT02272868
Fecal Microbial Transplant in Pediatric Crohn's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a double blind placebo control trial of fecal microbial transplantation for active Crohn's disease in patients 12 to 21 years of age.
Timeline
- Start
- 2015-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal Microbial Transplant | Other / unclassified | 90 ml | Other |
| Background | Omeprazole | Other / unclassified | 20 mg | — |
| Background | Rifaximin | Other / unclassified | 400 mg | Oral |
| Background | polyethylene glycol | Other / unclassified | 17 g | — |